安圖生物(603658.SH):全資子公司醫療器械生產許可證變更 涉及生產地址
格隆匯 10 月 20日丨安圖生物(603658.SH)公佈,公司全資子公司安圖實驗儀器(鄭州)有限公司(“安圖儀器”)於近日取得河南省藥品監督管理局換髮的《醫療器械生產許可證》,此次主要涉及生產地址的變更,變更後具體如下:
企業名稱:安圖實驗儀器(鄭州)有限公司;許可證編號:豫食藥監械生產許20150120號;住所:鄭州經濟技術開發區經開第十五大街199號;生產地址:鄭州經濟技術開發區經開第十五大街199號;鄭州經濟技術開發區明理南路172號。
生產範圍:原分類目錄:Ⅱ類:6840臨牀檢驗分析儀器;6870軟件Ⅲ類:6840臨牀檢驗分析儀器;新分類目錄:Ⅱ類:21-05:體外診斷類軟件;22-04:免疫分析設備;22-06:微生物分析設備;22-09尿液及其他樣本分析設備;22-15檢驗及其他輔助設備
法定代表人:劉聰;企業負責人:劉聰;有效期至:2021年10月20日。
此次醫療器械生產許可證變更主要是基於安圖儀器生產場地的增加,對後續生產經營無明顯影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.